D. Berman Lab
Daniel S. Berman, MD, is director of cardiac imaging at Cedars-Sinai and professor of medicine at UCLA. He received his medical degree at the University of California, San Francisco, and then trained in internal medicine, nuclear medicine and cardiology at the University of California, Davis. In 1977, he was recruited to Cedars-Sinai to initiate a new program in nuclear cardiology, one of the first of its kind in the U.S. Since then, his career has been devoted to clinical research in developing, validating and applying noninvasive cardiac imaging methods for the detection of coronary disease and for risk assessment of patients once the diagnosis of coronary disease has been made.
- Assessing Diagnostic Value of Non-Invasive Fractional Flow Reserve Derived From Computed Tomography (FFRCT) in Coronary Care (ADVANCE)
- 18F-fluoride (18F-NaF) PET for Identifying Coronary Atherosclerotic Plaques
- 18-F Sodium Fluoride (18F-NaF) PET for the Assessment of Bioprosthetic Aortic Valve Durability and Outcomes
Learn more about the scientists, faculty members, investigators and other healthcare professionals of the Daniel S. Berman Laboratory, whose dedicated efforts lead to groundbreaking discoveries.
Kwiecinski J, Berman DS, Lee SE, Dey D, Cadet S, Lassen ML, Jansen MA, Dweck MR, Newby DE, et al.
J Nucl Med. 2018 Sep 13. pii: jnumed.118.217885.
Betancur J, Otaki Y, Motwani M, Fish MB, Lemley M, Dey D, Gransar H, Tamarappoo B, Sharir T, Berman DS, Slomka PJ.
JACC Cardiovasc Imaging. 2018 Jul;11(7):1000-1009.
Hell MM, Motwani M, Otaki Y, Cadet S, Gransar H, Miranda-Peats R, Valk J, Slomka PJ, Cheng VY, Rozanski A, Tamarappoo BK, Hayes S, Achenbach S, Berman DS, Dey D.
Eur Heart J Cardiovasc Imaging. 2017 Dec 1;18(12):1331-1339.